Navigation Links
Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
Date:9/22/2007

FRAZER, Pa., Sept. 21 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) requesting approval of TREANDA(R) (bendamustine HCl) for the treatment of patients with chronic lymphocytic leukemia (CLL). CLL is a slowly progressing blood and bone marrow disease with an estimated 15,000 new cases diagnosed every year in the United States, according to the National Cancer Institute. If approved, TREANDA would be the first new therapy approved by the FDA for the treatment of CLL since 2001. In August 2007, the FDA granted orphan drug designation to TREANDA for this indication.

"This is our first regulatory filing for TREANDA and a significant milestone for our growing oncology portfolio," said Dr. Lesley Russell, Executive Vice President, Worldwide Medical and Regulatory Operations. "We also are developing TREANDA for the treatment of non-Hodgkin's lymphoma and are planning additional submissions for Cephalon oncology compounds to the FDA over the next 12 months."

The NDA is based on a large, international multi-center Phase 3 clinical trial that evaluated the safety and efficacy of bendamustine HCl, the active ingredient in TREANDA, compared to chlorambucil in patients who were not previously treated for their disease. Chlorambucil is an FDA-approved first- line therapy for patients with CLL. In the pivotal trial, bendamustine HCl met both primary endpoints, overall response and progression-free survival and demonstrated an acceptable tolerability profile. The company anticipates that results from this study will be released at the upcoming American Society of Hematology (ASH) annual meeting in December 2007.

The company also is studying TREANDA for the treatment of patients with indolent (or slowly-progressing) non-Hodgkin's lymphoma (NHL), who are refractory to the monoclonal antibody rituximab. Pending positive results from this o
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Provigil Patent Extension Accorded To Cephalon
2. Novartis files application with FDA for Zometa
3. Morepan to file new drug applications with the USFDA
4. Mini motor for micromedical applications
5. Perfusion bioreactor could enhance stem cell research and application in the future
6. Prostate Cancer Can Be Treated By Application Of LASER Technology
7. Varied Applications of Adult Stem Cells to Treat Host of Disorders in Human
8. Venus Remedies Files 5th International Patent Application
9. NICE supports application of advanced biological therapies as treatment option for acute psoriasis
10. Roche puts in an Application to Use Herceptin for Treatment in Her-2 positive breast cancer
11. New Drug Application Submitted for Investigational Antibiotic Doripenem
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... that an "expressive therapy" group intervention conducted by ... disclose their health status and improves their social ... their relationships., "Medication alone is totally insufficient," said ... director of the Women,s HIV Program at UCSF. ... effective antiretroviral therapy but far too many are ...
(Date:7/11/2014)... Recently, iFitDress.com, a leading online supplier of wedding ... new collection of evening dresses for 2014. ... all these beautiful items are provided with big discounts, ... offer is July 22. , According to the ... to customer satisfaction. On the company’s website, sincere customer ...
(Date:7/11/2014)... Organic Crop Farming in Australia ... limelight over the past decade. According to IBISWorld industry ... be an alternative food eaten only by minority groups, ... food.” Organic crop farmers have reaped the benefits of ... herbs over the past five years. Industry revenue is ...
(Date:7/11/2014)... patients, the era of personalized medicine may be just ... Stem Cell researcher Min Yu and scientists at Massachusetts ... July 11 study in Science , Yu and ... circulating through the blood streams of six patients. Some ... metastasis, which travel to and establish secondary tumors in ...
(Date:7/11/2014)... Alliance Labs announced that they will be ... Begley Jr, airing later this year 2014, via Discovery ... episode, Innovations will explore DocuSol® Kids, a mini-enema containing ... glycol base designed to give adolescents general constipation relief. ... a hyperosmotic laxative by drawing water into the bowel ...
Breaking Medicine News(10 mins):Health News:'Expressive therapy" intervention assists women living with HIV 2Health News:Worldwide Chic Ladies Can Buy Cheap Evening Dresses at iFitDress.com 2Health News:Organic Crop Farming in Australia Industry Market Research Report Now Available from IBISWorld 2Health News:Organic Crop Farming in Australia Industry Market Research Report Now Available from IBISWorld 3Health News:Organic Crop Farming in Australia Industry Market Research Report Now Available from IBISWorld 4Health News:Alliance Labs & DocuSol® to be Featured in Upcoming Episode of Innovations 2
... asked to investigate Australia’s crippled mental health services and ... that the funding would triple for Australia's mental health ... set up if the Government accepts the demands of ... release mental health patients from institutions into the community. ...
... long waiting lists. He said that they can take their health ... He guaranteed that one can open the door to legal action ... , By this the framework in place is maintained ... care that is essential. Clement said this while, speaking at a ...
... The device, which is used for treating obstructive sleep apnea ... to be beneficial in resolving heart abnormalities, says Belgium physicians. ... that pump less effectively. ,"Not only are ... side of the heart was dilated and the heart muscle ...
... the alleged leak of question papers of the MD/MS and ... Institute of Medical Sciences (AIIMS), // has been identified ... Medical College. ,Satish Kumar (26),an MD (Paediatric) student, ... two other doctors have been taken into custody by ...
... would be targeted towards controlling the spread of three ... are haunting the Asian region. Furthermore, a 'Programme for ... Action' would be launched neat year. ,The main focus ... financial constraints that prevent the realization of the sixth ...
... announced on Thursday about its overseas expansion of acquiring ... ,This is the fourth acquisition announced by the ... takeover of Romania's Terapia for $324 million, GlaxoSmithKline Plc's ... and assets to Senetek Plc's auto-injector device by the ...
Cached Medicine News:Health News:Control And Prevention Of Three Diseases To Be Discussed: European Commission 2
(Date:1/15/2014)... , Jan. 15, 2014 As health officials across ... virus, select Meijer pharmacies in Michigan ... to eligible patients, enabling Meijer pharmacists to administer tests and, ... set by a physician participating in the study. ...
(Date:1/15/2014)... Corporation (the "Company") (NASDAQ: CLSN ) today ... to purchase an aggregate of approximately $15 million of ... offering, led by a dedicated health care fund. ... these investors pursuant to which the Company agreed to ...
(Date:1/15/2014)... , Jan. 15, 2014  Humberto C. Antunes,  Galderma  ... Award" from the Journal of Drugs in Dermatology ... Clinical Conference (ODAC). The event is January 17-20, 2014, at the ... . The ODAC is a ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4
... FHC ) today announced that it has received ... Brazilian Ministry of Health. It is anticipated,that shipments will ... by UNAIDS and other global public agencies for its,highly ... pleased that Brazilian women will continue to have access ...
... 78% to 100% with ... Masimo,s PI measurement, IRVINE, Calif., ... Read-Through Motion and Low,Perfusion pulse oximetry, reported that a new independent ... (PI),to improve detection of congenital heart defects (CHD) in newborns with,duct-dependent ...
Cached Medicine Technology:Female Health Company Receives Brazilian Order: Four Million FC Female Condoms 2New Research Shows Masimo Perfusion Index (PI) Effective in the Noninvasive Detection of Congenital Heart Defects (CHD) in Newborns 2New Research Shows Masimo Perfusion Index (PI) Effective in the Noninvasive Detection of Congenital Heart Defects (CHD) in Newborns 3New Research Shows Masimo Perfusion Index (PI) Effective in the Noninvasive Detection of Congenital Heart Defects (CHD) in Newborns 4
... 12 L/min of Type I ultrapure water, ... Super-Q Plus System is designed to provide ... been pretreated by reverse osmosis, distillation or ... water quality which exceeds Type I ASTM/CAP/NCCLS ...
... for speed, stability and durability. Back-lighted ... modes, multiple units of measure, piece ... print, and GLP/GMP/ISO output including date ... Built-in, motor-driven internal calibration mass ...
... for speed, stability and durability. Back-lighted ... modes, multiple units of measure, piece ... print, and GLP/GMP/ISO output including date ... Touch-key calibration with external weights only ...
... Portable - Battery Powered (6 size AA ... conversion (g, ct, oz, ozt, GN, dwt, ... Counting and Percent Measure functions, Auto Print. ... Optional AC adapter may be ordered for ...
Medicine Products: